Ratnakar Securities Pvt. Ltd.

AARTI DRUGS LTD.

NSE : AARTIDRUGSBSE : 524348ISIN CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse : Aarti

BSE464.00-9.75 (-2.06 %)

PREV CLOSE ( ) 473.75

OPEN PRICE ( ) 468.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 17382

TODAY'S LOW / HIGH ( )459.10 471.95

52 WK LOW / HIGH ( )312.5 634.9

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 28-09 1984

Management Info

Prakash M Patil - Chairman Rashesh C Gogri - Managing Director

Registered Office

Address Plot No N 198,M I D C,Tarapur Village - Patembhi, Taluka Palghar,
Thane,
Maharashtra-401506

Phone 022-24019025

Email investorrelations@aartidrugs.com

Website www.aartidrugs.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

07May Aarti Drugs informs about disclosure
In continuation to its intimation dated August 3, 2024 vide reference nu..

04Feb Aarti Drugs informs about acquisition
With reference to the query raised by BSE through email dated February 4..

30Jan Aarti Drugs gets nod to invest Rs 25 c
Aarti Drugsâ€™ board has approved the investment in equity shares of Pin..

30Jan Aarti Drugs climbs on getting nod to i
Aarti Drugs is currently trading at Rs. 406.65, up by 9.25 points or 2.3..

10Jan Aarti Drugs inks pact to acquire 26.25
Aarti Drugs has signed and executed the Share Subscription and Sharehold..

Financials

in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	614.8	1573.1
Gross Profit	706.8	1987.6
Operating Profit	903.7	2762.3
Net Sales	6229.6	21736.5

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE) 10524.65 (3.40%)	M.Cap ( in Cr)26311.63
RPG Life Sciences (BSE) 2339.50 (4.07%)	M.Cap ( in Cr)3869.30
Abbott India (BSE) 31545.15 (0.22%)	M.Cap ( in Cr)67031.24
Concord Biotech (BSE) 2110.55 (2.44%)	M.Cap ( in Cr)22079.77
Onesource Specialty (BSE) 2024.35 (2.45%)	M.Cap ( in Cr)23165.86

Shareholding Pattern

	MUTUAL FUNDS/UTI	8.75%
	PROMOTERS	55.48%
	NON-INSTITUTION	32.57%
	FI/BANKS/INSURANCE	0.08%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
DSP Small Cap Fund-Reg(G)	1.34
ICICI Pru Pharma He...	0.96
DSP Healthcare Fund...	0.96
DSP Value Fund-Reg(G)	0.26
Motilal Oswal Nifty...	0.18
Bandhan BSE Healthc...	0.10

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

AARTI DRUGS LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES